The Global Pellet Therapy Market Size is expected to grow at a CAGR of 14.27% during the forecast period from 2022 to 2032.

Hormone pellets are subcutaneous implants that emit bioidentical hormones derived from plants. Hormone pellet therapy is a treatment that replaces or regulates hormones in both men and women, using estrogen, testosterone, or a combination of hormones. Compounded hormones are hormone mixtures created specifically for an individual by a pharmacy or laboratory. The majority of females may benefit from hormone pellet therapy to address menopausal symptoms.

Hormone pellets are implants that are inserted beneath the skin by a healthcare expert. They produce hormones known as bioidentical hormones. Bioidentical hormones are derived from plants and are equivalent to the hormones found in the human body. A healthcare expert will numb the skin while making a tiny incision, generally in the hip area, for injecting hormone pellets. Then, one or more hormone pellets will be inserted beneath the skin. Furthermore, people of any gender can choose hormone pellet therapy, but menopausal women are the most common users.

Driving Factors

The primary factor driving the acceptance of pellet therapy is its ability to maintain a consistent flow of hormones within the body, hence avoiding adverse repercussions.  This strategy is suitable for people who do not want synthetic hormones injected into their bodies because the hormones supplied are obtained from nature. Furthermore, postmenopausal women are more susceptible to hormonal imbalances and their consequences. As a result, they have a higher probability to undergo estrogen pellet treatment implants for women, whereas testosterone pellet therapy for men offers a variety of benefits, particularly for males as they age.

In addition, a rising number of major corporations in the research and development of alternative treatments has resulted in the availability of newly developed products to the market. Furthermore, due to additional factors such as the immediate absorption of hormones into the bloodstream while avoiding the liver and gastrointestinal system, and the absence of the need to use external creams or gels regularly, body patches, or oral medicine, the demand for pellet therapy is expected to drive the market. Additionally, rising awareness of hormone deficiency and disorders is expected to drive market growth. Over the course of the forecast period, the global pellet therapy market is anticipated to experience lucrative opportunities due to the advancement of bioidentical hormone replacement therapy and the use of telemedicine for hormone replacement therapy.

Report Coverage

This research report categorizes the market for the global pellet therapy market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the pellet therapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the pellet therapy market.

Market Segmentation

By Therapy Type Insights

The estrogen therapy segment is dominating the market with the largest revenue share over the forecast period.

On the basis of therapy type, the global pellet therapy market is segmented into estrogen therapy, testosterone therapy, progestogen therapy, and others. Among these, the estrogen therapy segment is dominating the market with the largest revenue share of 57.6% over the forecast period. This dominance had been attributed to a rise in the number of women experiencing menopause. For instance, according to the American Congress of Obstetricians and Gynecologists, around 6,000 women in the United States reach menopause each day. Furthermore, as women become more aware of the serious implications of menopause, which can cause disorders and discomfort, they are increasingly turning to hormone therapies such as estrogen pellet therapy implants.

By Types Insights

The women segment is witnessing significant CAGR growth over the forecast period.

On the basis of types, the global pellet therapy Market is segmented into women and men. Among these, the women segment is witnessing significant CAGR growth over the forecast period. This growth can be attributed to the increased use of hormone pellet therapy as an improved form of hormone delivery. Because of the hormone pellet’s efficient and progressive delivery technique, which has fewer adverse effects than oral or injectable hormones, and there is less incidence of concerns connected to poor absorption, which can be troublesome with hormone creams, gels, or patches. As a result of increased female awareness and low side effects, the pellet therapy market is predicted to expand fast throughout the forecast period.

By End-Uses Insights

The hospital segment accounted for the largest revenue share of more than 57.2% over the forecast period.

On the basis of end-uses, the global pellet therapy market is segmented into hospitals, clinics, rehabilitation centers, and others. Among these, the hospital segment is dominating the market with the largest revenue share of 57.2% over the forecast period. They offer patients more individualized counseling than clinics. But hospitals are also connected to research centers and medical institutions to provide patients with additional care and security.

Regional Insights

North America dominates the market with the largest market share over the forecast period.

North America, on the contrary, is expected to grow the fastest during the forecast period. One of the key factors driving the expansion of the pellet treatment market in North America, particularly in the US and Canada, is the growing geriatric population. The primary drivers of this market are likely to be a rise in the usage of pellet therapy among women for both post-menopausal and menopausal management. Furthermore, hormone pellet therapy is becoming more popular in the United States as women seek a more easy and natural approach to obtain hormone therapy.

The Europe market is expected to register a substantial CAGR growth rate during the forecast period. Hormone pellet treatment has been utilized in both men and women in Europe for decades, which has resulted in an abundance of scientific research concerning the benefits and safety of this method. Major product releases, manufacturer collaboration agreements, and attractive reimbursement rules are among the causes responsible for the region's greatest market share.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global pellet therapy along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Market Players

• SottoPelle
• Novartis AG
• Orion Pharma AB
• Full Life Wellness Center
• BioTE Medical, LLC
• Merck KGaA
• Pfizer Inc.
• TherapeuticsMD, Inc.
• Papillon Medical
• United Pharmacy
• Noven Pharmaceuticals, Inc.
• Hisamitsu Pharmaceutical Co., Inc.
• GeneScience Pharmaceuticals Co., Ltd.
• Actiza Pharmaceutical Private Limited
• Defy Medical
• Neuva Aesthetics
• ZRT Laboratory
• Bayer AG
• Allergan

Key Market Developments

• On September 2022, Microsoft and Novo Nordisk have formed a new strategic partnership to combine Microsoft's computational services, cloud, and artificial intelligence (AI) capabilities with Novo Nordisk's medicine discovery, development, and data science capabilities. Microsoft is offering AI technology, foundational science models, and knowledge through the agreement, and is collaborating with Novo Nordisk's data scientists and domain specialists from early research and development domains to accelerate Novo Nordisk's R&D.

• On September 2022, BioTE Medical, LLC., a high-growth, specialized medical practice-building firm in the hormone optimization arena, announced a collaboration with IMAC Holdings, Inc., a regenerative rehabilitation company focusing on treating musculoskeletal and neurological disorders. IMAC will add specific Biote services to its network of outpatient clinics that provide orthopedic, regenerative, and advanced non-surgical medical procedures as a result of this collaboration.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2032. Spherical Insights has segmented the Global Pellet Therapy Market based on the below-mentioned segments:

Pellet Therapy Market, Therapy Type Analysis

• Estrogen Therapy
• Testosterone Therapy
• Progestogen Therapy
• Others

Pellet Therapy Market, Types Analysis

• Women
• Men

Pellet Therapy Market, End Users Analysis

• Hospitals
• Clinics
• Rehabilitation Centers
• Others

Pellet Therapy Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa